A double-blind study of randomized patients with ulcerative colitis ( Mayo score 5 and 10 , including a sigmoidoscopy subscore 2 ) to dersalazine sodium 1200 mg/12 h , mesalazine 1200 mg/12 h , or placebo for 4 weeks .